Patents by Inventor Karen Naylor

Karen Naylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240190854
    Abstract: Compounds of the formula (I) and pharmaceutically acceptable salts thereof: (I) wherein the substituents are defined in the specification. The compounds are hyperpolarisation activated cyclic-nucleotide modulated ion channel 2 (HCN2) inhibitors. Also disclosed are pharmaceutical compositions comprising the compounds, and the use of the compounds for the treatment or prevention of medical conditions mediated by HCN2, including neuropathic pain.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 13, 2024
    Applicant: King's College London
    Inventors: Peter A. McNaughton, Karen Williams, Sue Cramp, Alan Naylor
  • Publication number: 20240174639
    Abstract: Compounds of the formula (I) and pharmaceutically acceptable salts thereof: (I) wherein the substituents are defined in the specification. The compounds are hyperpolarisation activated cyclic-nucleotide modulated ion channel 2 (HCN2) inhibitors. Also disclosed are pharmaceutical compositions comprising the compounds, and the use of the compounds for the treatment or prevention of medical conditions mediated by HCN2, including neuropathic pain.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 30, 2024
    Applicant: King's College London
    Inventors: Peter A. McNaughton, Karen Williams, Sue Cramp, Alan Naylor
  • Publication number: 20240174663
    Abstract: Compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein the substituents are defined in the specification. The compounds are hyperpolarisation activated cyclic-nucleotide modulated ion channel 2 (HCN2) inhibitors. Also disclosed are pharmaceutical compositions comprising the compounds, and the use of the compounds for the treatment or prevention of medical conditions mediated by HCN2, including neuropathic pain.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 30, 2024
    Applicant: King's College London
    Inventors: Peter A. McNaughton, Karen Williams, Sue Cramp, Alan Naylor
  • Publication number: 20230119352
    Abstract: A video interface device, the device including a camera; an optically transparent enclosure, the enclosure configured to enclose the camera and configured for sanitization; a height-adjustable mount connected to the optically transparent enclosure; a computer display connected to the height-adjustable mount; and a cart connected to the height-adjustable mount, wherein the camera and the computer display are configured to facilitate communication with at least one remote system. A method of constructing a video interface device, including enclosing a first camera in an optically-transparent enclosure, the enclosure being configured for sanitization; attaching the first camera in the optically-transparent enclosure to a height-adjustable mount; attaching a computer display to the height-adjustable mount; and attaching a cart to the height-adjustable mount, such that the first camera and the computer display are configured to facilitate communication with at least one remote system.
    Type: Application
    Filed: October 4, 2022
    Publication date: April 20, 2023
    Inventors: Alex Blate, Douglas Bennett, Tom Place, Garrett Goss, Paxton Scott, Anna Bennett, Anthony Randazzo, Karen Naylor